|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01099 SINOPHARM
Nominal 
20.550 -0.750 (-3.521%) Ranking Overview
Ranking based on 8 research report(s)
Average Ranking 2.38
|
Strong Buy (1)
0
|
Buy (2)
6
|
Hold (3)
1
|
Sell (4)
1
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 290.00 RMB (cts) | |
| Net Profit | 9,053.76 RMB (MIL) | DPS | 87.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 8,681.50 | 278.50 | 82.15 | -- | 9,228.00 | 7,876.40 |
| 2025 | 9,425.50 | 302.50 | 88.82 | -- | 10,217.00 | 8,291.60 |
| 2026 | 9,906.50 | 318.00 | 93.34 | -- | 11,219.00 | 8,744.70 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 9,228.00 | 296.00 | 89.00 | UBS | Buy | 28.60 | 26/08/2024 | |
| 2024 | 8,608.00 | 276.00 | -- | NOMURA | Buy | 28.46 | 17/10/2024 | |
| 2024 | 8,115.00 | 260.40 | 78.10 | CITIGROUP | Buy | 26.00 | 28/10/2024 | |
| 2024 | 9,087.00 | 291.00 | 87.20 | HUATAI FIN HLDGS HK | Buy | 25.30 | 26/08/2024 | |
| 2024 | 8,755.00 | 281.00 | 84.30 | MORGAN STANLEY | Overweight | 25.00 | 28/10/2024 | |
| 2024 | 9,056.00 | 290.20 | 87.50 | CLSA | OutPerform | 24.80 | 28/10/2024 | |
| 2024 | 8,303.00 | 266.00 | 80.00 | HSBC | Hold | 19.00 | 31/10/2024 | |
| 2024 | 7,876.40 | 252.40 | 76.47 | UOB | Sell | 18.00 | 29/10/2024 | |
| 2025 | 10,217.00 | 327.00 | 98.00 | UBS | -- | -- | 26/08/2024 | |
| 2025 | 9,348.00 | 300.00 | -- | NOMURA | -- | -- | 17/10/2024 | |
| 2025 | 8,928.00 | 286.50 | 85.90 | CITIGROUP | -- | -- | 28/10/2024 | |
| 2025 | 9,768.00 | 313.00 | 93.62 | HUATAI FIN HLDGS HK | -- | -- | 26/08/2024 | |
| 2025 | 9,503.00 | 305.00 | 91.63 | MORGAN STANLEY | -- | -- | 28/10/2024 | |
| 2025 | 9,931.00 | 318.20 | 96.00 | CLSA | -- | -- | 28/10/2024 | |
| 2025 | 8,946.00 | 287.00 | 86.00 | HSBC | -- | -- | 31/10/2024 | |
| 2025 | 8,291.60 | 265.70 | 80.20 | UOB | -- | -- | 29/10/2024 | |
| 2026 | 11,219.00 | 360.00 | 108.00 | UBS | -- | -- | 26/08/2024 | |
| 2026 | 10,057.00 | 323.00 | -- | NOMURA | -- | -- | 17/10/2024 | |
| 2026 | 9,689.00 | 310.90 | 93.20 | CITIGROUP | -- | -- | 28/10/2024 | |
| 2026 | 10,462.00 | 335.00 | 100.38 | HUATAI FIN HLDGS HK | -- | -- | 26/08/2024 | |
| 2026 | 9,756.00 | 313.00 | 93.47 | MORGAN STANLEY | -- | -- | 28/10/2024 | |
| 2026 | 11,119.00 | 356.30 | 107.50 | CLSA | -- | -- | 28/10/2024 | |
| 2026 | 9,661.00 | 310.00 | 93.00 | HSBC | -- | -- | 31/10/2024 | |
| 2026 | 8,744.70 | 280.20 | 83.93 | UOB | -- | -- | 29/10/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 21/11/2024 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 3,703,875 |
| %Change | -9.759% |
| EPS / (LPS) | RMB 1.190 |
| NBV Per Share (¥) | RMB 24.207 |